These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6385263)

  • 1. Mitoxantrone in relapsed and refractory acute leukemia.
    Prentice HG; Robbins G; Ma DD; Ho AD
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):32-5. PubMed ID: 6385263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
    Moore JO; Olsen GA
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):41-6. PubMed ID: 6385265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia.
    Paciucci PA; Cuttner J; Holland JF
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):36-40. PubMed ID: 6385264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential studies on the role of mitoxantrone in the treatment of acute leukaemia.
    Prentice HG; Robbins G; Ma DD; Ho AD
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():57-63. PubMed ID: 6362878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
    Meyer P; Ho AD; Ehninger G; Mjaaland I; Heidemann E; Seither E
    Invest New Drugs; 1985; 3(2):203-6. PubMed ID: 3860490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential studies on the role of mitoxantrone in the treatment of acute leukemia.
    Prentice HG; Wimperis JZ; Robbins G
    Invest New Drugs; 1985; 3(2):207-12. PubMed ID: 3894280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
    Ehninger G; Ho AD; Meyer P; Mjaaland I; Ostendorf P; Seither E
    Onkologie; 1985 Jun; 8(3):146-8. PubMed ID: 3895096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
    Sampi K; Kaneko Y; Maseki N; Kumai R; Sakurai M; Hattori M
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1453-7. PubMed ID: 4015120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I-II trial of mitoxantrone in acute leukemia.
    Arlin ZA; Silver R; Cassileth P; Armentrout S; Gams R; Daghestani A; Coleman M; Schoch I; Dukart G
    Cancer Treat Rep; 1985 Jan; 69(1):61-4. PubMed ID: 3855386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
    Sampi K; Ogawa M; Kimura I; Ohnoshi T; Yamada K; Masaoka T; Wakui A; Meguro S; Nagai K; Kitani T
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3021-7. PubMed ID: 3464230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I-II trial of mitoxantrone in acute leukemia: an interim report.
    Arlin ZA; Dukart G; Schoch I; Reisman A; Moore J; Silver RA; Cassileth P; Bertino J; Gams R
    Invest New Drugs; 1985; 3(2):213-7. PubMed ID: 3860491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phase II study of a new anthraquinone antineoplastic agent, mitoxantrone, in hematological malignancies].
    Sampi K; Honda T; Hayashi Y; Hattori M
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1538-9. PubMed ID: 6347083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone, vincristine, and prednisone in adults with relapsed or primarily refractory acute lymphocytic leukemia and terminal deoxynucleotidyl transferase positive blastic phase chronic myelocytic leukemia.
    Paciucci PA; Keaveney C; Cuttner J; Holland JF
    Cancer Res; 1987 Oct; 47(19):5234-7. PubMed ID: 3476201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A phase II study of mitoxantrone in acute leukemia. Hanshin Cooperative Study Group of Hematological Disorders].
    Masaoka T; Oguma S; Shibata H; Nagai K; Horiuchi A; Kitani T; Yonezawa T; Kawagoe H; Yasunaga K
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2793-9. PubMed ID: 3753025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoxantrone in refractory acute leukemia in children: a phase I study.
    Starling KA; Mulne AF; Vats TS; Schoch I; Dukart G
    Invest New Drugs; 1985; 3(2):191-5. PubMed ID: 4019122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phase II study of mitoxantrone in patients with acute leukemia].
    Kimura K; Yoshikawa S; Yoshikawa H; Yamada K; Hirano M; Ikeda Y; Ohta K; Ohara K; Kobayashi M; Shirakawa S
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2573-80. PubMed ID: 3740858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mitoxantrone and conventional-dose cytosine arabinoside for relapsed and refractory acute leukemia].
    Wakita A; Murase T; Uchida T; Fujiwara Y; Tanaka M; Ohkita T
    Gan To Kagaku Ryoho; 1992 May; 19(5):653-7. PubMed ID: 1580638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of mitoxantrone in acute leukemia.
    Masaoka T; Shibata H; Oguma S; Nagai K; Kitani T; Horiuchi A; Yasunaga K; Yonezawa T; Kawagoe H
    Invest New Drugs; 1985; 3(2):197-201. PubMed ID: 3860489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of mitoxantrone in children.
    Ungerleider RS; Pratt CB; Vietti TJ; Holcenberg JS; Kamen BA; Glaubiger DL; Cohen LF
    Cancer Treat Rep; 1985 Apr; 69(4):403-7. PubMed ID: 3857968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol.
    Martino R; Guardia R; Altés A; Sureda A; Brunet S; Sierra J
    Haematologica; 1999 Mar; 84(3):226-30. PubMed ID: 10189387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.